Aleph Zero
Privacy-enhancing public blockchain with instant finality. Aleph Zero is built for enterprise, Web 3.0, and DeFi use-cases. Aleph Zero is a proof-of-stake public blockchain. We combined an original, aBFT consensus protocol with a customized substrate stack. Currently, we’re working on enhancing the platform with a privacy framework based on Zero-knowledge Proofs (ZKPs) and secure Multi-Party Computation (sMPC) to empower developers with a unique approach to private smart contracts. During a laboratory test, Aleph Zero’s peer-reviewed consensus protocol (AlephBFT) achieved 89,600 tx/s with a 416 ms confirmation time in a decentralized test setting of 112 AWS nodes spread across five continents. Aleph Zero’s real-world performance, especially under heavy l network load, is yet to be determined. The Aleph Zero Consensus Protocol has been officially peer-reviewed and accepted for publication in the conference proceedings of advances in financial technology 2019.
Learn more
Scopus
Scopus offers free features to non-subscribed users as Scopus Preview. Researchers use Scopus Preview to assist with research, such as searching for authors and learning more about Scopus content coverage and source metrics. Scopus is an abstract and citation database of peer-reviewed literature including scientific journals, books, and conference proceedings. Scopus provides a comprehensive overview of worldwide research output in the fields of science, technology, medicine, social sciences, and arts and humanities. Scopus is the largest abstract and citation database of peer-reviewed literature: scientific journals, books and conference proceedings. Delivering a comprehensive overview of the world's research output in the fields of science, technology, medicine, social sciences, and arts and humanities, Scopus features smart tools to track, analyze and visualize research. You can make sure that critical research from around the world is not missed when you choose Scopus.
Learn more
Claude for Life Sciences
Claude for Life Sciences is an AI-powered research platform developed by Anthropic, tailored explicitly for life sciences workflows such as drug discovery, experimental design, and regulatory documentation. The solution connects Claude’s large-language-model capabilities with key research environments and data sources, linking to platforms like lab information systems, genomic analysis tools, and biomedical databases, so scientists can move seamlessly from hypothesis generation through data interpretation to publication-ready outputs. The system also introduces “skills” and specialized connectors built for life-science use cases; for example, a skill for single-cell RNA-seq quality control, or integration with spatial-biology toolchains, enabling meaningful dialogue with analytic pipelines rather than simply raw prompts. By embedding into existing workflows, it reports performance that exceeds human baseline on protocol comprehension tasks, supports natural-language queries.
Learn more
Schrödinger
Transform drug discovery and materials research with advanced molecular modeling. Our physics-based computational platform integrates differentiated solutions for predictive modeling, data analytics, and collaboration to enable rapid exploration of chemical space. Our platform is deployed by industry leaders worldwide for drug discovery, as well as for materials science in fields as diverse as aerospace, energy, semiconductors, and electronics displays. The platform powers our own drug discovery efforts, from target identification to hit discovery to lead optimization. It also drives our research collaborations to develop novel medicines for critical public health needs. With more than 150 Ph.D. scientists on our team, we invest heavily in R&D. We’ve published over 400 peer-reviewed papers that demonstrate the strength of our physics-based approaches, and we’re continually pushing the limits of computer modeling.
Learn more
